Patients Undergoing Gynecologic Cancer Surgery Face Insurance-Based Disparities and Financial Toxicity Sep 14, 2022 For a study, researchers sought to assess the association between insurance status and clinical... Read More
Financial Toxicity in Gynecologic Cancers: Patient-Reported Drivers Sep 12, 2022 For a study, researchers sought to comprehend the effects that treatment-related financial burden... Read More
Financial Toxicity Has ‘Profound Impact’ in Gynecologic Oncology Jun 13, 2022 Patients undergoing surgery for gynecologic cancer, particularly those without insurance,... Read More
Healthcare Costs for PPI or P-CAB-First for GERD May 9, 2022 The objective of this study was to compare actual healthcare expenditures in GERD patients who... Read More
Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC). May 2, 2022 To conduct a cost-effectiveness analysis of stereotactic body radiotherapy (SBRT) versus... Read More
NMOSD & MOGAD Financial Burdens Impact QOL Mar 11, 2022 Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein-antibody... Read More
Racial–Ethnic and Socioeconomic Disparities in Guideline-Adherent Treatment for Uterine Cancer Oct 20, 2021 The goal of this study was to assess the relationship between race-ethnicity, and neighborhood... Read More